Article

Essilor makes contribution in wake of tsunami disaster

Dallas—In the aftermath of the devastation caused by the tsunami in many parts of Asia and east Africa last December, Essilor International is donating 1 million Singapore dollars (about $612,000) to the Singapore Red Cross Society.

Dallas-In the aftermath of the devastation caused by the tsunami in many parts of Asia and east Africa last December, Essilor International is donating 1 million Singapore dollars (about $612,000) to the Singapore Red Cross Society.

Essilor has operations in Asia, but none of its employees was injured in the wake of the disaster.

"As we begin this new year, our hearts are burdened for the Asian countries that have suffered from the tsunami," said Hubert Sagnieres, president of Essilor of America.

The division will consist of three regional business units: managed care and anti-reflective technology licensing, technical services, and sales support.

Under the new arrangement, Jim Rabbitt, Steve Mills, and James Schrick will become new regional vice presidents leading the three regional business units. Jim Blasco will become vice president of managed care and technology licensing, while K.C. Haffey will assume responsibility for technology transfer management. Dave Cuffe will serve as director of technical services, and Ben Collier as sales operations manager.

The division is led by Bob Colucci, who became its president in October.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.